{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:51:30Z","timestamp":1788871890487,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"CAFP\/Capes"},{"name":"CAPES\/PRODOC"},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PIBIC\/CNPq"},{"name":"DOCFIX\/Fapergs"},{"name":"PROBIC\/Fapergs"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.phrs.2015.02.001","type":"journal-article","created":{"date-parts":[[2015,2,12]],"date-time":"2015-02-12T14:17:35Z","timestamp":1423750655000},"page":"34-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Montelukast potentiates the anticonvulsant effect of phenobarbital in mice: An isobolographic analysis"],"prefix":"10.1016","volume":"94","author":[{"given":"Juliana","family":"Fleck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseane Righes","family":"Marafiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Cl\u00e1udia","family":"Jesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Rodrigo","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Magno","family":"Rambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Fernando","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.phrs.2015.02.001_bib0295","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s40263-013-0078-6","article-title":"Causes of CNS inflammation and potential targets for anticonvulsants","volume":"27","author":"Falip","year":"2013","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.phrs.2015.02.001_bib0300","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.yfrne.2011.12.002","article-title":"Cytokines and brain excitability","volume":"33","author":"Galic","year":"2012","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.phrs.2015.02.001_bib0305","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.expneurol.2013.05.010","article-title":"The dual role of TNF-alpha and its receptors in seizures","volume":"247","author":"Balosso","year":"2013","journal-title":"Exp Neurol"},{"issue":"4","key":"10.1016\/j.phrs.2015.02.001_bib0310","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.neuroscience.2008.01.005","article-title":"Modulation of pentylenetetrazol-induced seizures by prostaglandin E2 receptors","volume":"152","author":"Oliveira","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2015.02.001_bib0315","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","article-title":"Epilepsy and brain inflammation","volume":"244","author":"Vezzani","year":"2013","journal-title":"Exp Neurol"},{"key":"10.1016\/j.phrs.2015.02.001_bib0320","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2012.04.004","article-title":"The role of inflammation in epileptogenesis","volume":"69","author":"Vezzani","year":"2013","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2015.02.001_bib0325","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/epi.12461","article-title":"Cyclooxygenase-2 in epilepsy","volume":"55","author":"Rojas","year":"2014","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.phrs.2015.02.001_bib0330","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/glia.22311","article-title":"Blood\u2013brain barrier dysfunction, TGFbeta signaling, and astrocyte dysfunction in epilepsy","volume":"60","author":"Heinemann","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2015.02.001_bib0335","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.expneurol.2014.05.002","article-title":"Commentary on Kaushik et al.: Prostaglandin D2 is crucial for seizure suppression and postictal sleep. Novel evidence supporting a role for prostanoid receptors in seizure control","volume":"257","author":"Mello","year":"2014","journal-title":"Exp Neurol"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2015.02.001_bib0340","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0006-8993(90)90579-Z","article-title":"Cysteinyl-leukotriene production during limbic seizures triggered by kainic acid","volume":"515","author":"Simmet","year":"1990","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.phrs.2015.02.001_bib0345","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0006-8993(00)02560-9","article-title":"Phenidone prevents kainate-induced neurotoxicity via antioxidant mechanisms","volume":"874","author":"Kim","year":"2000","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.phrs.2015.02.001_bib0350","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/jpet.103.059824","article-title":"Inverse agonist activity of selected ligands of the cysteinyl-leukotriene receptor 1","volume":"309","author":"Dupre","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.phrs.2015.02.001_bib0355","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.plefa.2011.04.003","article-title":"Modulation of leukotriene D4 attenuates the development of seizures in mice","volume":"85","author":"Rehni","year":"2011","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"5","key":"10.1016\/j.phrs.2015.02.001_bib0360","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4103\/1673-5374.130083","article-title":"Increased expression of Notch1 in temporal lobe epilepsy: animal models and clinical evidence","volume":"9","author":"Liu","year":"2014","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.phrs.2015.02.001_bib0365","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.neuroscience.2014.07.058","article-title":"Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood\u2013brain barrier dysfunction","volume":"277","author":"Lenz","year":"2014","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.phrs.2015.02.001_bib0370","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3565(25)32765-5","article-title":"Electrophysiological response of cerebellar Purkinje neurons to leukotriene D4 and B4","volume":"219","author":"Palmer","year":"1981","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 2","key":"10.1016\/j.phrs.2015.02.001_bib0375","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/epi.12191","article-title":"Pharmacoresistant epilepsy: unmet needs in solving the puzzle(s)","volume":"54","author":"Weaver","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2015.02.001_bib0380","series-title":"Epilepsy - a comprehensive textbook. vol. 1","first-page":"659","article-title":"Febrile seizures","author":"Camfield","year":"2008"},{"key":"10.1016\/j.phrs.2015.02.001_bib0385","series-title":"Drug synergism and dose\u2013effect analysis","author":"Tallarida","year":"2000"},{"key":"10.1016\/j.phrs.2015.02.001_bib0390","series-title":"Paxinos and Franklin's the mouse brain in stereotaxic coordinates","author":"Paxinos","year":"2012"},{"issue":"Pt 10","key":"10.1016\/j.phrs.2015.02.001_bib0395","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1093\/brain\/awp217","article-title":"Functional definition of seizure provides new insight into post-traumatic epileptogenesis","volume":"132","author":"D\u2019Ambrosio","year":"2009","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.phrs.2015.02.001_bib0400","first-page":"329","article-title":"The history of barbiturates a century after their clinical introduction","volume":"1","author":"Lopez-Munoz","year":"2005","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"11","key":"10.1016\/j.phrs.2015.02.001_bib0405","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1947601912440575","article-title":"Quantitative methods for assessing drug synergism","volume":"2","author":"Tallarida","year":"2011","journal-title":"Genes Cancer"},{"issue":"2","key":"10.1016\/j.phrs.2015.02.001_bib0410","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0031-6997(25)00026-2","article-title":"What is synergy?","volume":"41","author":"Berenbaum","year":"1989","journal-title":"Pharmacol Rev"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2015.02.001_bib0415","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0304-3959(02)00041-6","article-title":"The interaction index: a measure of drug synergism","volume":"98","author":"Tallarida","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.phrs.2015.02.001_bib0420","doi-asserted-by":"crossref","first-page":"901902","DOI":"10.1155\/2014\/901902","article-title":"Role of inflammatory mediators in the pathogenesis of epilepsy","volume":"2014","author":"Shimada","year":"2014","journal-title":"Mediators Inflamm"},{"issue":"4","key":"10.1016\/j.phrs.2015.02.001_bib0425","doi-asserted-by":"crossref","first-page":"8345","DOI":"10.3390\/ijms14048345","article-title":"Intercellular signaling pathway among endothelia, astrocytes and neurons in excitatory neuronal damage","volume":"14","author":"Takemiya","year":"2013","journal-title":"Int J Mol Sci"},{"issue":"1 Suppl","key":"10.1016\/j.phrs.2015.02.001_bib0430","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5698\/1535-7511-14.s2.15","article-title":"Inflammatory processes, febrile seizures, and subsequent epileptogenesis","volume":"14","author":"Choy","year":"2014","journal-title":"Epilepsy Curr"},{"issue":"11","key":"10.1016\/j.phrs.2015.02.001_bib0435","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","article-title":"Brain inflammation in epilepsy: experimental and clinical evidence","volume":"46","author":"Vezzani","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.phrs.2015.02.001_bib0440","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.expneurol.2013.12.002","article-title":"Prostaglandin D(2) is crucial for seizure suppression and postictal sleep","volume":"253","author":"Kaushik","year":"2014","journal-title":"Exp Neurol"},{"issue":"2\u20133","key":"10.1016\/j.phrs.2015.02.001_bib0445","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.eplepsyres.2006.06.009","article-title":"The neuronal excitability time-dependently changes after lipopolysaccharide administration in mice: possible role of cyclooxygenase-2 induction","volume":"71","author":"Akarsu","year":"2006","journal-title":"Epilepsy Res"},{"issue":"5","key":"10.1016\/j.phrs.2015.02.001_bib0450","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/mol.107.041210","article-title":"Seizure-induced up-regulation of P-glycoprotein at the blood\u2013brain barrier through glutamate and cyclooxygenase-2 signaling","volume":"73","author":"Bauer","year":"2008","journal-title":"Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.phrs.2015.02.001_bib0455","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1528-1167.2010.02889.x","article-title":"Prophylactic, prandial rofecoxib treatment lacks efficacy against acute PTZ-induced seizure generation and kindling acquisition","volume":"52","author":"Claycomb","year":"2011","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.phrs.2015.02.001_bib0460","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1476-5381.2010.00765.x","article-title":"Celecoxib treatment restores pharmacosensitivity in a rat model of pharmacoresistant epilepsy","volume":"160","author":"Schlichtiger","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.phrs.2015.02.001_bib0465","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.neuro.2008.08.008","article-title":"NMDA-induced seizure intensity is enhanced in COX-2 deficient mice","volume":"29","author":"Toscano","year":"2008","journal-title":"Neurotoxicology"},{"issue":"Pt 3","key":"10.1016\/j.phrs.2015.02.001_bib0470","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1113\/jphysiol.2006.105569","article-title":"PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons","volume":"572","author":"Sang","year":"2006","journal-title":"J Physiol"},{"issue":"1\u20132","key":"10.1016\/j.phrs.2015.02.001_bib0475","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jneuroim.2006.12.012","article-title":"Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury","volume":"184","author":"Ahmad","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.phrs.2015.02.001_bib0480","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-2094-6-5","article-title":"Microglial inhibition of neuroprotection by antagonists of the EP1 prostaglandin E2 receptor","volume":"6","author":"Carlson","year":"2009","journal-title":"J Neuroinflamm"},{"issue":"20","key":"10.1016\/j.phrs.2015.02.001_bib0485","doi-asserted-by":"crossref","first-page":"10996","DOI":"10.1073\/pnas.191351298","article-title":"Neural roles for heme oxygenase: contrasts to nitric oxide synthase","volume":"98","author":"Baranano","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"30","key":"10.1016\/j.phrs.2015.02.001_bib0490","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1073\/pnas.0804852105","article-title":"S-nitrosylation\/activation of COX-2 mediates NMDA neurotoxicity","volume":"105","author":"Tian","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.phrs.2015.02.001_bib0495","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.neuint.2011.03.025","article-title":"Role of oxidative stress in epileptic seizures","volume":"59","author":"Shin","year":"2011","journal-title":"Neurochem Int"},{"issue":"2","key":"10.1016\/j.phrs.2015.02.001_bib0500","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1152\/jn.00696.2004","article-title":"Endogenous PGE2 regulates membrane excitability and synaptic transmission in hippocampal CA1 pyramidal neurons","volume":"93","author":"Chen","year":"2005","journal-title":"J Neurophysiol"},{"issue":"Pt 2","key":"10.1016\/j.phrs.2015.02.001_bib0505","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1093\/brain\/awl318","article-title":"Blood\u2013brain barrier leakage may lead to progression of temporal lobe epilepsy","volume":"130","author":"van Vliet","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2015.02.001_bib0510","first-page":"1","article-title":"Chronic gliosis and behavioral deficits in mice following repetitive mild traumatic brain injury","author":"Mannix","year":"2014","journal-title":"J Neurosurg"},{"issue":"10","key":"10.1016\/j.phrs.2015.02.001_bib0515","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.ajem.2014.06.028","article-title":"Ischemia-modified albumin in patients with seizure","volume":"32","author":"Balta","year":"2014","journal-title":"Am J Emerg Med"},{"issue":"5","key":"10.1016\/j.phrs.2015.02.001_bib0520","doi-asserted-by":"crossref","first-page":"e1431","DOI":"10.1542\/peds.2013-3106","article-title":"Cognitive outcomes in febrile infection-related epilepsy syndrome treated with the ketogenic diet","volume":"134","author":"Singh","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.phrs.2015.02.001_bib0525","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.phrs.2014.05.009","article-title":"Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury","volume":"86","author":"Esposito","year":"2014","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.phrs.2015.02.001_bib0530","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.phrs.2014.04.009","article-title":"Hydrogen sulfide attenuates hypoxia-induced neurotoxicity through inhibiting microglial activation","volume":"84","author":"Zhang","year":"2014","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.phrs.2015.02.001_bib0535","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.phrs.2014.02.010","article-title":"Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia","volume":"81","author":"Mango","year":"2014","journal-title":"Pharmacol Res"},{"issue":"12","key":"10.1016\/j.phrs.2015.02.001_bib0540","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1111\/j.1745-7254.2006.00438.x","article-title":"Cysteinyl leukotriene receptor 1 is involved in N-methyl-d-aspartate-mediated neuronal injury in mice","volume":"27","author":"Ding","year":"2006","journal-title":"Acta Pharmacol Sin"},{"issue":"12","key":"10.1016\/j.phrs.2015.02.001_bib0545","first-page":"1241","article-title":"Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on transient global cerebral ischemia in rats","volume":"24","author":"Zhang","year":"2003","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.phrs.2015.02.001_bib0550","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.phrs.2013.08.001","article-title":"Montelukast prevents microparticle-induced inflammatory and functional alterations in human bronchial smooth muscle cells","volume":"76","author":"Fogli","year":"2013","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.phrs.2015.02.001_bib0555","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2165\/00003088-199630060-00002","article-title":"Clinically important drug interactions with anticoagulants. An update","volume":"30","author":"Harder","year":"1996","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"10.1016\/j.phrs.2015.02.001_bib0560","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1742-7843.2008.00227.x","article-title":"In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products","volume":"102","author":"Hellum","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"10.1016\/j.phrs.2015.02.001_bib0565","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.diabres.2013.12.033","article-title":"Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin","volume":"104","author":"He","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.phrs.2015.02.001_bib0570","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10928-014-9355-3","article-title":"Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 2: 6-mercaptopurine and its interaction with methotrexate","volume":"41","author":"Ogungbenro","year":"2014","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"11","key":"10.1016\/j.phrs.2015.02.001_bib0575","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1528-1157.2000.tb00111.x","article-title":"Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed","volume":"41","author":"Deckers","year":"2000","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.phrs.2015.02.001_bib0580","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.braindev.2012.04.001","article-title":"Open study of pranlukast add-on therapy in intractable partial epilepsy","volume":"35","author":"Takahashi","year":"2013","journal-title":"Brain Dev"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181500016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104366181500016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T19:36:23Z","timestamp":1747596983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104366181500016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":58,"alternative-id":["S104366181500016X"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2015.02.001","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Montelukast potentiates the anticonvulsant effect of phenobarbital in mice: An isobolographic analysis","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2015.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}